NRSN Stock Price
$1.08 (+1.00%)
At 2024-05-30 20:00:00 ESTNeuroSense Therapeutics Ltd.
(NASDAQ:NRSN) 
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin an...
Website: https://www.neurosense-tx.com
Founded: 2017
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
NRSN - Daily
Date: 2024-05-31, O: 1.1, H: 1.13, L: 1.02, C: 1.08, Volume: 106,098
10EMA: 1.1420EMA: 1.2050EMA: 1.32100EMA: 1.34200EMA: 1.32
10EMA: 1.1420EMA: 1.2050EMA: 1.32100EMA: 1.34200EMA: 1.32
NASDAQ:NRSN Stock Key Statistics
| Basic Info: | |||
| Market Cap: | 16.30M | Exchange: | NASDAQ |
| Shares Outstanding: | 15,602,000 | Number of Employees: | 11 |
| Advanced Info: | |||
| Beta: | 1.56 | Return on Equity (ROE) ttm: | -602.00% |
| Return on Assets (ROA) ttm: | -152.70% | Earnings per Share (EPS) ttm: | -0.83 |
| Book value per Share: | -0.12 | Cash per Share: | 0.18 |
| Current ast per Share: | 0.2 | ||
| Key Ratios: | |||
| P/E ttm: | P/E forward: | ||
| P/E ttm high: | P/E ttm low: | ||
| P/S ttm: | P/B ttm: | 2.71 | |
| P/FCF ttm: | 2072.44 | PEG ratio: | |
| Cash Ratios: | |||
| Cash Ratio ttm: | 0.77 | Quick Ratio ttm: | 0.82 |
| Current Ratio ttm: | 0.84 | ||
| Margins: | |||
| Gross Margin ttm: | EBITDA Margin ttm: | ||
| Operating Margin ttm: | Net Income Margin ttm: | ||
| Dividends: | |||
| Trailing Dividend yield: | Forward Dividend yield: | ||
| Payout Ratio ttm: | Ex-Dividend date: | None | |
| Target Prices: | |||
| Target Price High: | 7 USD | Target Price Low: | 7 USD |
| Target Price Mean: | 7 USD | Number of Analysts: | 1 |
| Debt: | |||
| Debt Ratio ttm: | 0.04 | Debt to Equity ttm: | -0.08 |
| Total Net Debt: | -2.54M | ||
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.